Medical Abortion Provided by Nurse-Midwives or Physicians in a High Resource Setting: A Cost-Effectiveness Analysis

被引:26
作者
Sjostrom, Susanne [1 ]
Kallner, Helena Kopp [1 ,2 ]
Simeonova, Emilia [3 ]
Madestam, Andreas [4 ]
Gemzell-Danielsson, Kristina [1 ]
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, Stockholm, Sweden
[2] Karolinska Inst, Dept Clin Sci, Danderyds Hosp, Dept Obstet & Gynecol, Stockholm, Sweden
[3] Johns Hopkins Univ, Carey Sch Business, Baltimore, MD USA
[4] Stockholm Univ, Dept Econ, Stockholm, Sweden
来源
PLOS ONE | 2016年 / 11卷 / 06期
基金
瑞典研究理事会;
关键词
ACTING REVERSIBLE CONTRACEPTION; UNINTENDED PREGNANCY; UNITED-STATES; POSTABORTION CONTRACEPTION; SAFE ABORTION; CARE; CHOICE; COHORT; TRIAL;
D O I
10.1371/journal.pone.0158645
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective The objective of the present study is to calculate the cost-effectiveness of early medical abortion performed by nurse-midwifes in comparison to physicians in a high resource setting where ultrasound dating is part of the protocol. Non-physician health care professionals have previously been shown to provide medical abortion as effectively and safely as physicians, but the cost-effectiveness of such task shifting remains to be established. Study design A cost effectiveness analysis was conducted based on data from a previously published randomized-controlled equivalence study including 1180 healthy women randomized to the standard procedure, early medical abortion provided by physicians, or the intervention, provision by nurse-midwifes. A 1.6% risk difference for efficacy defined as complete abortion without surgical interventions in favor of midwife provision was established which means that for every 100 procedures, the intervention treatment resulted in 1.6 fewer incomplete abortions needing surgical intervention than the standard treatment. The average direct and indirect costs and the incremental cost-effectiveness ratio (ICER) were calculated. The study was conducted at a university hospital in Stockholm, Sweden. Results The average direct costs per procedure were EUR 45 for the intervention compared to EUR 58.3 for the standard procedure. Both the cost and the efficacy of the intervention were superior to the standard treatment resulting in a negative ICER at EUR -831 based on direct costs and EUR -1769 considering total costs per surgical intervention avoided. Conclusion Early medical abortion provided by nurse-midwives is more cost-effective than provision by physicians. This evidence provides clinicians and decision makers with an important tool that may influence policy and clinical practice and eventually increase numbers of abortion providers and reduce one barrier to women's access to safe abortion.
引用
收藏
页数:9
相关论文
共 46 条
[41]   The cost-effectiveness analysis of serplulimab versus regorafenib for treating previously treated unresectable or metastatic microsatellite instability-high or deficient mismatch repair colorectal cancer in China [J].
Ma, Yue ;
Zhou, Jiting ;
Ye, Yuxin ;
Wang, Xintian ;
Ma, Aixia ;
Li, Hongchao .
FRONTIERS IN ONCOLOGY, 2023, 13
[42]   Cost-Effectiveness Analysis of Ezetimibe as the Add-on Treatment to Moderate-Dose Rosuvastatin versus High-Dose Rosuvastatin in the Secondary Prevention of Cardiovascular Diseases in China: A Markov Model Analysis [J].
Yang, Han ;
Li, Nan ;
Zhou, Youlian ;
Xiao, Zhilan ;
Tian, Haoming ;
Hu, Ming ;
Li, Sheyu .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 :157-165
[43]   The Real-World Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Stenting in High-Risk Patients: Propensity Score-Matched Analysis of a Single-Centre Experience [J].
Ariyaratne, Thathya V. ;
Ademi, Zanfina ;
Huq, Molla ;
Rosenfeldt, Franklin ;
Duffy, Stephen J. ;
Parkinson, Bonny ;
Yap, Cheng-Hon ;
Smith, Julian ;
Billah, Baki ;
Yan, Bryan P. ;
Brennan, Angela L. ;
Tran, Lavinia ;
Reid, Christopher M. .
APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2018, 16 (05) :661-674
[44]   Analysis of efficacy and cost-effectiveness of high-dose arabinoside versus daunorubicin chemotherapy in older adult patients with acute myeloid leukemia by cytogenetic risk profile: retrospective review from China [J].
Huang, Bin-Tao ;
Wang, Yu ;
Du, Qing-Feng ;
Yang, Jun ;
Yu, Jessica ;
Zeng, Qing-Chun ;
Xu, Na ;
Zhang, Jin-Fang ;
Xu, Lu-Lu ;
Luo, Xu-Jing ;
Wei, Yong-Qiang ;
Liu, Xiao-Li .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (04) :474-481
[45]   Atezolizumab compared to chemotherapy for first-line treatment in non-small cell lung cancer with high PD-L1 expression: a cost-effectiveness analysis from US and Chinese perspectives [J].
Cheng, Shuqiao ;
Pei, Rui ;
Li, Jianhuang ;
Li, Bin ;
Tang, Lanhua ;
Yin, Tao ;
Liu, Shao .
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (18)
[46]   Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation [J].
Varani, Elisabetta ;
Guastaroba, Paolo ;
Di Tanna, Gian Luca ;
Saia, Francesco ;
Balducelli, Marco ;
Campo, Gianluca ;
Vignali, Luigi ;
Rossi, Rosario ;
Manari, Antonio ;
Piovaccari, Giancarlo ;
De Palma, Rossana ;
Marzocchi, Antonio .
EUROINTERVENTION, 2010, 5 (08) :953-961